What is it used for?
ZEPBOUND® is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Limitations of Use ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.ZEPBOUND® is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Limitations of Use ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- tirzepatidetirzepatide
- Form and strength
- INJECTION, SOLUTION · 2.5 mg / 0.5 mL; INJECTION, SOLUTION · 5 mg / 0.5 mL; INJECTION, SOLUTION · 7.5 mg / 0.5 mL; INJECTION, SOLUTION · 10 mg / 0.5 mL; INJECTION, SOLUTION · 12.5 mg / 0.5 mL; INJECTION, SOLUTION · 15 mg / 0.5 mL; INJECTION, SOLUTION · 4.17 mg / 1 mL; INJECTION, SOLUTION · 8.33 mg / 1 mL; INJECTION, SOLUTION · 12.5 mg / 1 mL; INJECTION, SOLUTION · 16.7 mg / 1 mL; INJECTION, SOLUTION · 20.8 mg / 1 mL; INJECTION, SOLUTION · 25 mg / 1 mLINJECTION, SOLUTION · 2.5 mg / 0.5 mL; INJECTION, SOLUTION · 5 mg / 0.5 mL; INJECTION, SOLUTION · 7.5 mg / 0.5 mL; INJECTION, SOLUTION · 10 mg / 0.5 mL; INJECTION, SOLUTION · 12.5 mg / 0.5 mL; INJECTION, SOLUTION · 15 mg / 0.5 mL; INJECTION, SOLUTION · 4.17 mg / 1 mL; INJECTION, SOLUTION · 8.33 mg / 1 mL; INJECTION, SOLUTION · 12.5 mg / 1 mL; INJECTION, SOLUTION · 16.7 mg / 1 mL; INJECTION, SOLUTION · 20.8 mg / 1 mL; INJECTION, SOLUTION · 25 mg / 1 mL
- Manufacturer / applicant
- ELI LILLY AND COMPANYELI LILLY AND COMPANY
Injection: Clear, colorless to slightly yellow solution in pre-filled single-dose pens, single-dose vials, multi-dose vials, or single-patient-use KwikPens, each available in the following strengths. The multi-dose vials and single-patient-use KwikPen each contain 4 doses: Single-dose Pen or Vial …Injection: Clear, colorless to slightly yellow solution in pre-filled single-dose pens, single-dose vials, multi-dose vials, or single-patient-use KwikPens, each available in the following strengths. The multi-dose vials and single-patient-use KwikPen each contain 4 doses: Single-dose Pen or Vial …
Safety and clinical review
In rats, tirzepatide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether ZEPBOUND causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been …In rats, tirzepatide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether ZEPBOUND causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been …
- Risk of Thyroid C-Cell TumorsRisk of Thyroid C-Cell Tumors
- Severe Gastrointestinal Adverse ReactionsSevere Gastrointestinal Adverse Reactions
- Acute Kidney Injury Due to Volume DepletionAcute Kidney Injury Due to Volume Depletion
- Acute Gallbladder DiseaseAcute Gallbladder Disease
- Acute PancreatitisAcute Pancreatitis
- Hypersensitivity ReactionsHypersensitivity Reactions
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Zepbound used for?
ZEPBOUND® is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Limitations of Use ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.ZEPBOUND® is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Limitations of Use ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Zepbound should I ask about?
INJECTION, SOLUTION · 2.5 mg / 0.5 mL; INJECTION, SOLUTION · 5 mg / 0.5 mL; INJECTION, SOLUTION · 7.5 mg / 0.5 mL; INJECTION, SOLUTION · 10 mg / 0.5 mL; INJECTION, SOLUTION · 12.5 mg / 0.5 mL; INJECTION, SOLUTION · 15 mg / 0.5 mL; INJECTION, SOLUTION · 4.17 mg / 1 mL; INJECTION, SOLUTION · 8.33 mg / 1 mL; INJECTION, SOLUTION · 12.5 mg / 1 mL; INJECTION, SOLUTION · 16.7 mg / 1 mL; INJECTION, SOLUTION · 20.8 mg / 1 mL; INJECTION, SOLUTION · 25 mg / 1 mLINJECTION, SOLUTION · 2.5 mg / 0.5 mL; INJECTION, SOLUTION · 5 mg / 0.5 mL; INJECTION, SOLUTION · 7.5 mg / 0.5 mL; INJECTION, SOLUTION · 10 mg / 0.5 mL; INJECTION, SOLUTION · 12.5 mg / 0.5 mL; INJECTION, SOLUTION · 15 mg / 0.5 mL; INJECTION, SOLUTION · 4.17 mg / 1 mL; INJECTION, SOLUTION · 8.33 mg / 1 mL; INJECTION, SOLUTION · 12.5 mg / 1 mL; INJECTION, SOLUTION · 16.7 mg / 1 mL; INJECTION, SOLUTION · 20.8 mg / 1 mL; INJECTION, SOLUTION · 25 mg / 1 mL
Read the primary sourceWhat determines the price of Zepbound?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Zepbound?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.